,i #aagth ,,congress #b;d ,session ,h4 ,r4 #gffi ,,in ,,the ,,house ,,of ,,representatives ,may #f1 #bjbb,ms4 ,matsui introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to require guidance on extending expiration dates for certain drugs1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,drug ,shortages ,shelf ,life ,extension ,act4 #b4 ,extending expiration dates for certain drugs 7a7 ,in general ,not later than #a year after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary7 shall issue draft guidance1 or revise existing guidance1 to address recommendations for sponsors of applications submitted under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 or section #cea of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bfb7 regarding-- 7#a7 the submission of stability testing data in such applications1 including considerations for data requirements that could be streamlined or reduced to facilitate faster review of longer proposed expiration dates2 7#b7 establishing in the labeling of drugs the longest feasible expiration date scientifically supported by such data1 taking into consideration how extended expiration dates may-- 7,a7 help prevent or mitigate drug shortages2 and 7,b7 affect product quality2 and 7#c7 the use of innovative approaches for drug and combination product stability modeling to support initial product expiration dates and expiration date extensions4 7b7 ,report ,not later than #b years after the date of enactment of this ,act1 and again #b years thereafter1 the ,secretary shall submit to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives a report that includes-- 7#a7 the number of drugs for which the ,secretary has requested the manufacturer make a labeling change regarding the expiration date2 and 7#b7 for each drug for which the ,secretary has requested a labeling change with respect to the expiration date1 information regarding the circumstances of such request1 including-- 7,a7 the name and dose of such drug2 7,b7 the rationale for the request2 7,c7 whether the drug1 at the time of the request1 was listed on the drug shortage list under section #ejf;,e of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cef;e71 or was at risk of shortage2 7,d7 whether the request was made during a public health emergency declared under section #cai of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bdg;d72 and 7,e7 whether the manufacturer made the requested change by the requested date1 and for instances where the manufacturer does not make the requested change1 the manufacturer's justification for not making the change1 if the manufacturer agrees to provide such justification for inclusion in the report4